Retour
77
Fourchette du Jour
34,21 €
36,00 €
Fourchette 52 Semaines
11,26 €
46,67 €
Volume
632 511
Moyenne 50J / 200J
37,72 €
/
27,42 €
Clôture Précédente
35,50 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -45,0 | 0,3 |
| P/B | 69,3 | 2,9 |
| ROE % | -113,0 | 3,7 |
| Net Margin % | -43,5 | 3,8 |
| Rev Growth 5Y % | 87,3 | 10,0 |
| D/E | 4,4 | 0,2 |
Objectif de Cours des Analystes
Hold
50,67 €
+43.9%
Low: 47,00 €
High: 55,00 €
P/E Prévisionnel
14,7
BPA Prévisionnel
2,41 €
Croissance BPA (est.)
+0,0%
CA Est.
590 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
6,12 €
3,60 € – 8,34 €
|
1,4 B | 2 |
| FY2029 |
5,66 €
3,33 € – 7,71 €
|
1,2 B | 4 |
| FY2028 |
5,09 €
0,44 € – 8,94 €
|
1,1 B | 6 |
Points Clés
Revenue grew 87,34% annually over 5 years — strong growth
Debt/Equity of 4,42 — high leverage
Negative free cash flow of -40,02M
PEG of 0,83 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 943,84%
Capital efficient — spends only 2,74% of revenue on capex
Croissance
Revenue Growth (5Y)
87,34%
Revenue (1Y)1031,18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-112,97%
ROIC-15,88%
Net Margin-43,53%
Op. Margin-32,45%
Sécurité
Debt / Equity
4,42
Current Ratio1,40
Interest Coverage-2,13
Valorisation
P/E Ratio
-45,00
P/B Ratio69,31
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1031,18% | Revenue Growth (3Y) | 200,88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 87,34% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 158,32M | Net Income (TTM) | -68,92M |
| ROE | -112,97% | ROA | -21,02% |
| Gross Margin | 97,21% | Operating Margin | -32,45% |
| Net Margin | -43,53% | Free Cash Flow (TTM) | -40,02M |
| ROIC | -15,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4,42 | Current Ratio | 1,40 |
| Interest Coverage | -2,13 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -45,00 | P/B Ratio | 69,31 |
| P/S Ratio | 19,59 | PEG Ratio | 0,83 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,10B | Enterprise Value | 3,11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 158,32M | 14,00M | 17,49M | 15,94M | 12,85M |
| Net Income | -68,92M | -130,39M | -78,50M | -41,02M | -34,58M |
| EPS (Diluted) | -0,80 | -1,66 | -1,21 | -0,67 | -0,70 |
| Gross Profit | 153,90M | 8,12M | 14,60M | 13,08M | 9,83M |
| Operating Income | -51,38M | -121,29M | -73,38M | -38,77M | -33,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 327,93M | 230,31M | 118,33M | 129,20M | 93,73M |
| Total Liabilities | 283,19M | 153,04M | 71,04M | 38,78M | 28,46M |
| Shareholders' Equity | 44,75M | 77,28M | 47,29M | 90,42M | 65,27M |
| Total Debt | 197,93M | 122,39M | 49,54M | 24,46M | 16,08M |
| Cash & Equivalents | 190,68M | 176,48M | 83,68M | 93,28M | 57,49M |
| Current Assets | 190,68M | 185,11M | 89,90M | 99,81M | 61,28M |
| Current Liabilities | 135,77M | 41,78M | 18,55M | 8,80M | 7,33M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#6 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026